The expansion of newborn screening: is reproductive benefit an appropriate pursuit?

Article metrics

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

REFERENCES

  1. 1

    Wilson, J. M. Q. & Jungner, G. Principles and Practice of Screening for Disease (World Health Organization, Geneva, 1968)

  2. 2

    American College of Medical Genetics. Newborn screening: toward a uniform screening panel and system. Genet. Med. 8 (Suppl. 1), 1–252 (2006)

  3. 3

    Lund, A. M. Neonatal metabolic screening in Denmark [abstract K058.02V] in 101st Annual Meeting of the German Society of Pediatrics (29 Sep–2 Oct 2005, Bremen) [online], (2005)

  4. 4

    Save Babies Through Screening Foundation of Canada. Diseases screened by province [online], (2006)

  5. 5

    Moyer, V. A., Calonge, N., Teutsch, S. M. & Botkin, J. R. Expanding newborn screening: process, policy, and priorities. Hastings Cent. Rep. 38, 32–39 (2008)

  6. 6

    Alexander, D. & van Dyck, P. C. A vision of the future of newborn screening. Pediatrics 117, 350–354 (2006)

  7. 7

    Bailey, D. B. Jr, Skinner, D. & Warren, S. F. Newborn screening for developmental disabilities: reframing presumptive benefit. Am. J. Public Health 95, 1889–1893 (2005)

  8. 8

    Bailey, D. B. Jr, Beskow, L. M., Davis, A. M. & Skinner, D. Changing perspectives on the benefits of newborn screening. Ment. Retard. Dev. Disabil. Res. Rev. 12, 270–279 (2006)

  9. 9

    Health Council of the Netherlands. Screening: Between Hope and Hype (Health Council of the Netherlands, The Hague, 2008)

  10. 10

    Miller, F. A., Robert, J. S. & Hayeems, R. Z. Questioning the consensus: managing carrier status results generated by newborn screening. Am. J. Public Health 99, 210–215 (2009)

  11. 11

    Borry, P., Fryns, J. P., Schotsmans, P. & Dierickx, K. Carrier testing in minors: a systematic review of guidelines and position papers. Eur. J. Hum. Genet. 14, 133–138 (2006)

  12. 12

    Hayeems, R. Z. et al. Informing parents about expanded newborn screening: influences on provider involvement. Pediatrics 124, 950–958 (2009)

  13. 13

    Dhondt, J. L. Implementation of informed consent for a cystic fibrosis newborn screening program in France: low refusal rates for optional testing. J. Pediatr. 147, S106–S108 (2005)

  14. 14

    Liebl, B. et al. Very high compliance in an expanded MS-MS-based newborn screening program despite written parental consent. Prev. Med. 34, 127–131 (2002)

  15. 15

    Faden, R., Chwalow, A. J., Holtzman, N. A. & Horn, S. D. A survey to evaluate parental consent as public policy for neonatal screening. Am. J. Public Health 72, 1347–1352 (1982)

  16. 16

    Faden, R. R., Holtzman, N. A. & Chwalow, A. J. Parental rights, child welfare, and public health: the case of PKU screening. Am. J. Public Health 72, 1396–1400 (1982)

  17. 17

    Knoppers, B. M. in New Horizons in Neonatal Screening: Proceedings of the 9th International Neonatal Screening Symposium & the 2nd Meeting of the International Society for Neonatal Screening, Lille, France, 13–17 September 1993 (eds Farriaux, J. P. & Dhondt, J.-L.) 15 (Elsevier Science, Amsterdam, 1994)

  18. 18

    O'Connor, A., Légaré, F. & Stacey, D. Risk communication in practice: the contribution of decision aids. BMJ 327, 736–740 (2003)

Download references

Author information

Correspondence to Yvonne Bombard.

Rights and permissions

Reprints and Permissions

About this article

Further reading